MedTrace Logo

TARGET Intracranial Aneurysm Coiling Registry

NCT01748903 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-07-24

No results posted yet for this study

Summary

The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be performed.

Conditions

  • Intracranial Aneurysms

Interventions

DEVICE

Target 360°, 2D Coils, Nano Coils

Sponsors & Collaborators

  • Stryker Neurovascular

    collaborator INDUSTRY

  • Mercy Health Ohio

    lead OTHER

Principal Investigators

  • Osama O Zaidat, MD, MS · Mercy Health St. Vincent Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2019-01-31
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01748903 on ClinicalTrials.gov